| Original language | English |
|---|---|
| Pages (from-to) | 1617-1621 |
| Number of pages | 5 |
| Journal | Blood |
| Volume | 131 |
| Issue number | 14 |
| DOIs | |
| Publication status | Published - 5 Apr 2018 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Blood, Vol. 131, No. 14, 05.04.2018, p. 1617-1621.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
AU - Wierz, Marina
AU - Pierson, Sandrine
AU - Guyonnet, Léa
AU - Viry, Elodie
AU - Lequeux, Audrey
AU - Oudin, Anaïs
AU - Niclou, Simone P.
AU - Ollert, Markus
AU - Berchem, Guy
AU - Janji, Bassam
AU - Guérin, Coralie
AU - Paggetti, Jerome
AU - Moussay, Etienne
N1 - Funding Information: This project was supported by Télévie (grants 7.4563.15, 7.4508.16, and 7.4571.15), the Luxembourg Institute of Health (HEMATEXO project), and the Luxembourg National Research Fund (FNR) PRIDE program grant 11012546/NEXTIMMUNE (M.O.). The National Cytometry Platform at the Luxembourg Institute of Health received funding by the European Regional Development Fund (F.E.D.E.R.) for the CyTOF instrument. Funding Information: The authors thank Dominique Revets (National Cytometry Platform, Luxembourg Institute of Health) and Petr Nazarov (Proteome and Genome Research Unit, Luxembourg Institute of Health) for their technical help. They also thank Carlo Croce and John Byrd (Ohio State University) for the kind gift of Em-TCL1 mouse and Martina Seiffert (DKFZ Heidelberg, Germany) for providing animals. Finally we thank Joshua Brown-Clay (Luxembourg Institute of Health) for editing the manuscript. This project was supported by T?l?vie (grants 7.4563.15, 7.4508.16, and 7.4571.15), the Luxembourg Institute of Health (HEMATEXO project), and the Luxembourg National Research Fund (FNR) PRIDE program grant 11012546/NEXTIMMUNE (M.O.). The National Cytometry Platform at the Luxembourg Institute of Health received funding by the European Regional Development Fund (F.E.D.E.R.) for the CyTOF instrument. Funding Information: The authors thank Dominique Revets (National Cytometry Platform, Luxembourg Institute of Health) and Petr Nazarov (Proteome and Genome Research Unit, Luxembourg Institute of Health) for their technical help. They also thank Carlo Croce and John Byrd (Ohio State University) for the kind gift of Em-TCL1 mouse and Martina Seiffert (DKFZ Heidelberg, Germany) for providing animals. Finally we thank Joshua Brown-Clay (Luxembourg Institute of Health) for editing the manuscript. This project was supported by Télévie (grants 7.4563.15, 7.4508.16, and 7.4571.15), the Luxembourg Institute of Health (HEMATEXO project), and the Luxembourg National Research Fund (FNR) PRIDE program grant 11012546/NEXTIMMUNE (M.O.). The National Cytometry Platform at the Luxembourg Institute of Health received funding by the European Regional Development Fund (F.E.D.E.R.) for the CyTOF instrument.
PY - 2018/4/5
Y1 - 2018/4/5
UR - https://www.scopus.com/pages/publications/85047642164
U2 - 10.1182/blood-2017-06-792267
DO - 10.1182/blood-2017-06-792267
M3 - Letter
C2 - 29439955
AN - SCOPUS:85047642164
SN - 0006-4971
VL - 131
SP - 1617
EP - 1621
JO - Blood
JF - Blood
IS - 14
ER -